150 related articles for article (PubMed ID: 27742261)
1. Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
Faller N; Limacher A; Méan M; Righini M; Aschwanden M; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Lämmle B; Cornuz J; Angelillo-Scherrer A; Matter CM; Husmann M; Banyai M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
Am J Med; 2017 Feb; 130(2):198-206. PubMed ID: 27742261
[TBL] [Abstract][Full Text] [Related]
2. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
[TBL] [Abstract][Full Text] [Related]
3. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Lauber S; Limacher A; Tritschler T; Stalder O; Méan M; Righini M; Aschwanden M; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Lämmle B; Cornuz J; Angelillo-Scherrer A; Matter CM; Husmann M; Banyai M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
Am J Med; 2018 Jun; 131(6):703.e7-703.e16. PubMed ID: 29307536
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study.
White RH; Brunson A; Romano PS; Li Z; Wun T
Circulation; 2016 May; 133(21):2018-29. PubMed ID: 27048765
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Aujesky D; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Baumgartner I; Kucher N
Thromb Haemost; 2011 Nov; 106(5):978-84. PubMed ID: 21833454
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
Leiss W; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Angelillo-Scherrer A; Cornuz J; Banyai M; Lämmle B; Husmann M; Egloff M; Aschwanden M; Rodondi N; Aujesky D
J Gen Intern Med; 2015 Jan; 30(1):17-24. PubMed ID: 25143224
[TBL] [Abstract][Full Text] [Related]
8. Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
Carruzzo P; Méan M; Limacher A; Aujesky D; Cornuz J; Clair C
Thromb Res; 2016 Feb; 138():74-79. PubMed ID: 26688323
[TBL] [Abstract][Full Text] [Related]
9. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
[TBL] [Abstract][Full Text] [Related]
10. Increasing Incidence and Declining Mortality After Cancer-Associated Venous Thromboembolism: A Nationwide Cohort Study.
Ording AG; Skjøth F; Søgaard M; Højen AA; Overvad TF; Noble S; Goldhaber SZ; Larsen TB
Am J Med; 2021 Jul; 134(7):868-876.e5. PubMed ID: 33631159
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N
Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967
[TBL] [Abstract][Full Text] [Related]
12. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.
Righini M; Van Es J; Den Exter PL; Roy PM; Verschuren F; Ghuysen A; Rutschmann OT; Sanchez O; Jaffrelot M; Trinh-Duc A; Le Gall C; Moustafa F; Principe A; Van Houten AA; Ten Wolde M; Douma RA; Hazelaar G; Erkens PM; Van Kralingen KW; Grootenboers MJ; Durian MF; Cheung YW; Meyer G; Bounameaux H; Huisman MV; Kamphuisen PW; Le Gal G
JAMA; 2014 Mar; 311(11):1117-24. PubMed ID: 24643601
[TBL] [Abstract][Full Text] [Related]
13. Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Husmann M; Hayoz D; Baldi T; Frauchiger B; Engelberger R; Amann-Vesti B; Baumgartner I; Kucher N
Eur Heart J; 2012 Apr; 33(7):921-6. PubMed ID: 22036872
[TBL] [Abstract][Full Text] [Related]
14. Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study.
Zöller B; Pirouzifard M; Sundquist J; Sundquist K
J Thromb Thrombolysis; 2017 May; 43(4):469-475. PubMed ID: 27990607
[TBL] [Abstract][Full Text] [Related]
15. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
[TBL] [Abstract][Full Text] [Related]
16. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
[TBL] [Abstract][Full Text] [Related]
18. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
[TBL] [Abstract][Full Text] [Related]
19. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: an observational analysis from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Gong J; Xie W; Kuang T; Wang C
Thromb Res; 2015 Apr; 135(4):582-7. PubMed ID: 25721935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
